Macrogenics Inc (MGNX)
3.21
-0.07
(-2.13%)
USD |
NASDAQ |
Nov 21, 16:00
3.39
+0.18
(+5.61%)
After-Hours: 20:00
Macrogenics Enterprise Value: 1.108M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 1.108M |
| November 20, 2024 | 5.501M |
| November 19, 2024 | 18.05M |
| November 18, 2024 | 19.94M |
| November 15, 2024 | 23.70M |
| November 14, 2024 | 38.77M |
| November 13, 2024 | 36.26M |
| November 12, 2024 | 56.97M |
| November 11, 2024 | 75.17M |
| November 08, 2024 | 72.66M |
| November 07, 2024 | 79.56M |
| November 06, 2024 | 62.62M |
| November 05, 2024 | 36.26M |
| November 04, 2024 | 31.86M |
| November 01, 2024 | 42.53M |
| October 31, 2024 | 29.35M |
| October 30, 2024 | 13.03M |
| October 29, 2024 | 9.266M |
| October 28, 2024 | 20.56M |
| October 25, 2024 | 18.68M |
| October 24, 2024 | 25.58M |
| October 23, 2024 | 46.92M |
| October 22, 2024 | 44.41M |
| October 21, 2024 | 41.90M |
| October 18, 2024 | 51.32M |
| Date | Value |
|---|---|
| October 17, 2024 | 51.94M |
| October 16, 2024 | 58.22M |
| October 15, 2024 | 49.43M |
| October 14, 2024 | 68.26M |
| October 11, 2024 | 59.48M |
| October 10, 2024 | 34.37M |
| October 09, 2024 | 28.72M |
| October 08, 2024 | 26.84M |
| October 07, 2024 | 24.96M |
| October 04, 2024 | 24.96M |
| October 03, 2024 | 22.45M |
| October 02, 2024 | 21.19M |
| October 01, 2024 | 14.91M |
| September 30, 2024 | 6.128M |
| September 27, 2024 | 59.71M |
| September 26, 2024 | 50.30M |
| September 25, 2024 | 50.30M |
| September 24, 2024 | 47.79M |
| September 23, 2024 | 51.56M |
| September 20, 2024 | 65.36M |
| September 19, 2024 | 72.26M |
| September 18, 2024 | 66.61M |
| September 17, 2024 | 70.69M |
| September 16, 2024 | 74.77M |
| September 13, 2024 | 91.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-45.99M
Minimum
Jun 16 2022
1.796B
Maximum
Apr 29 2021
527.59M
Average
285.58M
Median
Feb 11 2020
Enterprise Value Benchmarks
| KORU Medical Systems Inc | 155.69M |
| Apellis Pharmaceuticals Inc | 3.507B |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 56.31M |
| Revenue (Quarterly) | 110.71M |
| Total Expenses (Quarterly) | 56.52M |
| EPS Diluted (Quarterly) | 0.90 |
| Gross Profit Margin (Quarterly) | 98.31% |
| Profit Margin (Quarterly) | 50.86% |
| Earnings Yield | -49.22% |
| Normalized Earnings Yield | -49.22 |